Loading organizations...
§ Private Equity · Zhuhai, Guangdong
Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise is an investment firm.
Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise functions as a dedicated investment firm. Its operational scope centers on identifying and supporting ventures within specific high-growth industries. The firm's name indicates a connection to the Zhuhai Hengqin area, suggesting a regional base for its operations.
The firm has been observed participating in seed rounds, indicating a focus on early-stage investment opportunities for developing companies.
While the organization's name includes "Softbank," the provided evidence does not detail an explicit affiliation or partnership structure with the broader SoftBank Group.
The firm has been observed participating in seed rounds, indicating a focus on early-stage investment opportunities for developing companies.
While the organization's name includes "Softbank," the provided evidence does not detail an explicit affiliation or partnership structure with the broader SoftBank Group.
The investment strategy of Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise is concentrated on the Biopharma, Health Care, and Medical fields. This specialized focus allows the firm to develop expertise and networks relevant to these complex and evolving sectors, aiming to foster innovation and growth.
As an active participant in the venture ecosystem, the enterprise has demonstrated its commitment to early-stage companies. Its involvement in seed rounds highlights a preference for supporting nascent businesses during their foundational development phases. This approach is crucial for providing capital to startups as they work to establish their products and market presence.
The firm's full name, Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise, includes "Softbank," which may suggest a strategic alignment or a component of its identity. However, specific details regarding any direct affiliation or partnership structure with the broader SoftBank Group are not detailed in the available information. The enterprise operates as a private equity entity, contributing to the financial landscape for emerging companies in its target sectors.
Zhuhai Hengqin Softbank Xinchuang Equity Investment Management Enterprise has 1 tracked investment across 1 company. The latest tracked deal is $14.4M Series C in Huaguan Biotechnology in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 4, 2026 | Huaguan Biotechnology | $14.4M Series C | — | Changjiang Capital, Changzhou Qihang Synthetic Biology Venture Capital Fund, SDIC Venture Capital, Shunxi Fund |